F. Rodríguez

Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

P. Soler-Palacín, Á. Holguín, J. Losa, 2020, Scientific Reports.

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Once-daily antiretroviral therapy: Spanish Consensus Statement.

D. Podzamczer, J. Mallolas, J. Ena, 2005, The Journal of antimicrobial chemotherapy.

High efficacy of Resistance-guided retreatment of HCVpatients failing NS5A inhibitors in real world.

J. Crespo, J. Pascasio, J. Salmerón, 2019, Journal of hepatology.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

[Cardiovascular risk in human immunodeficiency virus-infected patients in Spain. CoRIS cohort, 2011].

J. Blanco, F. Segura, F. Gutiérrez, 2012, Enfermedades infecciosas y microbiologia clinica.

Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure

P. Soler-Palacín, Á. Holguín, J. Losa, 2021, The Journal of antimicrobial chemotherapy.

Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.

S. Meshnick, J. Miro, J. Gatell, 2008, Diagnostic microbiology and infectious disease.